Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Neuro Disease Start-Up Gains $30M in Early Funds

A start-up enterprise developing treatments for several neurological diseases that the company says are triggered by a common destructive protein, is raising $30 million its first venture financing round. . . . → Read More: Neuro Disease Start-Up Gains $30M in Early Funds

3-D Organ Printing Company Gains Seed Funds

A start-up enterprise seeking to create replacement human tissue and organs with three-dimensional printing is raising $1.8 million in seed capital. . . . → Read More: 3-D Organ Printing Company Gains Seed Funds

Synthetic DNA Start-Up Raises $13M in Early Funds

A company producing synthesized DNA for medical and other biotechnology applications is raising €11 million ($US 13 million) in its first venture funding round. . . . → Read More: Synthetic DNA Start-Up Raises $13M in Early Funds

Start-Up Lands $10M for Gene-Editing HIV Treatments

A new enterprise developing treatments using gene editing to eliminate HIV infections received $10 million in its seed funding round. . . . → Read More: Start-Up Lands $10M for Gene-Editing HIV Treatments

Forensic Genomics Company Spun-Off From Illumina

A new company is being established to provide genomics analysis systems for law enforcement, spun-off from a leading maker of genomics systems. . . . → Read More: Forensic Genomics Company Spun-Off From Illumina

University Spins Off Educational Robot Start-Up

A start-up enterprise spun-off from Harvard University is developing a learning system with robotics to teach computer coding to students. . . . → Read More: University Spins Off Educational Robot Start-Up

Gene Editing, Therapy Company Gains $83.5M in Venture Funds

A biotechnology company designing treatments with gene edits and transfers using benign viruses is raising $83.5 million in its second venture funding round. . . . → Read More: Gene Editing, Therapy Company Gains $83.5M in Venture Funds

Start-Up Applying Artificial Intelligence to New Drug Uses

A new enterprise is being formed to apply artificial intelligence to connect drugs in development to treatments for rare diseases and other unmet medical needs. . . . → Read More: Start-Up Applying Artificial Intelligence to New Drug Uses

Immune Disease Start-Up Raises $28M in Early Funds

A new company founded to develop treatments for diseases caused by problems with the immune system is raising $28.4 million in its first round of financing. . . . → Read More: Immune Disease Start-Up Raises $28M in Early Funds

Coalition to Make 10,000 Open-Access Synthetic Genes

A company with a process for creating synthetic DNA and a foundation promoting open access to biotechnology agreed to produce 10,000 synthetic genes made available at no cost to researchers. . . . → Read More: Coalition to Make 10,000 Open-Access Synthetic Genes